Mode
Text Size
Log in / Sign up

Observational study finds no association between ZFHX3 GGC repeat expansions and ALS risk

Observational study finds no association between ZFHX3 GGC repeat expansions and ALS risk
Photo by Nathan Rimoux / Unsplash
Key Takeaway
Consider repeat motif characteristics when assessing neurodegenerative disease risk, but association with ALS was not observed.

This observational research article investigated the potential association between ZFHX3 GGC repeat expansions and amyotrophic lateral sclerosis (ALS) risk. The study included 5,785 people with ALS and 7,982 healthy controls of European ancestry, examining repeat expansions as the exposure compared to healthy controls. The primary outcome was the association between these expansions and disease risk, with secondary outcomes focusing on repeat motif composition and configuration.

The main finding was no observed association between ZFHX3 GGC repeat expansions and ALS risk. However, the analysis identified 50 unique repeat motif compositions across 802 people with ALS and 800 healthy controls, and 11 distinct configurations that coded a pure polyglycine tract. These observations suggest that repeat motif characteristics, beyond just repeat allele length, may have relevance for neurodegenerative disease assessment.

The study did not report specific limitations, adverse events, or funding/conflict information. As an observational study, it cannot establish causality and the findings require confirmation in additional populations. The practice relevance is cautious, suggesting consideration of repeat motif composition and configuration may be important for assessing neurodegenerative disease risk, but this remains speculative without mechanistic or clinical validation.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background and objectivesA pathogenic GGC repeat expansion in the zinc finger homeobox 3 (ZFHX3) gene, encoding a pure polyglycine tract, is the cause of spinocerebellar ataxia type 4 (SCA4). Intermediate expansions of other SCA loci contribute to the risk of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease involving the progressive loss of motor neurons. There is increasing awareness of the role of short tandem repeat (STR) motif composition and configuration in disease pathogenicity. Given the genetic pleiotropy between ALS and SCA, this study aimed to evaluate whether ZFHX3 GGC expansions were associated with ALS and to characterise repeat motif composition. MethodsExpansionHunter v5 was used to genotype ZFHX3 GGC repeat sizes in short-read whole genome sequencing data from people with ALS and healthy controls of European ancestry. Repeat sizes were visually inspected using REViewer v2. Repeat motif configurations of Australian ALS cases and healthy controls were manually derived from REViewer images. Receiver operating characteristic (ROC) curve analysis and Youdens J statistic were performed to find a candidate repeat size threshold for association testing. Fishers exact tests were performed to evaluate the associations of repeat size and motif composition with disease status. ResultsAnalysis of 5,785 people with ALS and 7,982 healthy controls found no association between ZFHX3 GGC repeat expansions and disease risk. Fifty unique repeat motif compositions were identified across 802 people with ALS and 800 healthy controls. Of these, eleven distinct configurations coded a pure polyglycine tract which, when expanded, is canonical to SCA4, though no association with ALS was found. DiscussionAlthough no association was observed between ZFHX3 GGC repeat expansions and ALS, this study established the dynamic nature of ZFHX3 repeat motif composition and configuration. Unique motif compositions were identified both within and between repeat sizes, including the presence of pure polyglycine repeats. Consideration of repeat motif composition and configuration, in addition to repeat allele length, may be important for assessing neurodegenerative disease risk.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.